# Correction: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson’s disease: pooled analysis of patient level data from two randomized open-label studies

**Authors:** Joaquim J. Ferreira, Jee-Young Lee, Hyeo-il Ma, Beomseok Jeon, Werner Poewe, Angelo Antonini, Fabrizio Stocchi, Daniela M. Rodrigues, Miguel M. Fonseca, Guillermo Castilla-Fernández, Joerg Holenz, José-Francisco Rocha, Olivier Rascol

PMC · DOI: 10.1007/s00415-025-13122-z · Journal of Neurology · 2025-08-01

## Full-text entities

- **Diseases:** Parkinson's disease (MESH:D010300), pathological gambling (MESH:D005715)
- **Chemicals:** Opicapone (MESH:C549349), levodopa (MESH:D007980), WO2015110261 (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12316747/full.md

---
Source: https://tomesphere.com/paper/PMC12316747